Clinical Trial Update: Efficacy and Safety Trial to Evaluate the Sufentanil NanoTab® PCA System/15 mcg (Zalviso™) for Post-Operative Pain in Patients After Knee or Hip Replacement Surgery [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the Sufentanil NanoTab PCA System (Zalviso) for postoperative pain after knee or hip replacement completed; results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Pain

Drugs mentioned

• Zalviso (sufentanil)

Snippet

Sponsor: Talphera, Inc | Conditions: Post Operative Pain | Phase 3 | Status: COMPLETED | Results posted: 2014-02-03